The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 23, 2024
Filed:
Jan. 13, 2022
Applicant:
Phase Pharmaceuticals Llc, Dallas, TX (US);
Inventors:
G. Lynn Howard, Dallas, TX (US);
Nicholas J. Farina, Dallas, TX (US);
Edward J. Walters, Dallas, TX (US);
Christopher Howard, Dallas, TX (US);
Assignee:
pHase Pharmaceuticals LLC, Dallas, TX (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/137 (2006.01); A61K 9/00 (2006.01); A61K 9/20 (2006.01); A61K 47/12 (2006.01); A61K 47/26 (2006.01); A61K 47/38 (2006.01); A61P 3/08 (2006.01); A61P 37/08 (2006.01);
U.S. Cl.
CPC ...
A61K 31/137 (2013.01); A61K 9/006 (2013.01); A61K 9/2018 (2013.01); A61K 9/2054 (2013.01); A61K 47/12 (2013.01); A61K 47/26 (2013.01); A61K 47/38 (2013.01); A61P 3/08 (2018.01); A61P 37/08 (2018.01);
Abstract
The present disclosure provides sublingual epinephrine tablets and methods of treating anaphylaxis, methods for concomitant therapy during a cardiac event, treating hypoglycemia, and prophylaxis for immunotherapy, using sublingual epinephrine tablets.